China Pharmaceuticals and Healthcare Report - Q4 2014

Business Monitor International
September 10, 2014
197 Pages - SKU: BMI5325553
Countries covered: China

China Pharmaceuticals and Healthcare Report - Q4 2014

BMI View: A more 'rational' use of pharmaceuticals through pharmacoeconomics, and a crackdown onillegal rebates and corruption in China's pharmaceutical market could hinder the sector's growth potential.

However, over the long term, the government is likely to improve its investment in healthcare in order toretain public support.

Headline Expenditure Projections

Pharmaceuticals: CNY532.4bn (US$86.6bn) in 2013 to CNY616.1bn (US$99.3bn) in 2014; +15.7% inlocal currency and +14.7% in US dollar terms. Forecast broadly unchanged from Q313.

Healthcare: CNY3,230.8bn (US$525.4bn) in 2013 to CNY3,692.0bn (US$595.2bn) in 2014; +14.3% inlocal currency terms and +13.3% in US dollar terms. Forecast remains unchanged from Q313.



More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Russia Q4 2104 by Business Monitor International
BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in thecountry. With the EU and the US applying further ...
Pharmaceuticals and Healthcare Report - Greece Q4 2104 by Business Monitor International
BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over theremainder of 2014. The government will seek to reduce public spending ...
Pharmaceuticals and Healthcare Report - Finland Q4 2104 by Business Monitor International
BMI View: An ageing population and the subsequent increased consumption of high-value prescriptionmedicines for the treatment of long-term illnesses will place a greater strain on ...
Pharmaceuticals and Healthcare Report - Oman Q4 2014 by Business Monitor International
BMI View: Despite its small size in comparison with other GCC countries, Oman will remain an attractivemarket to multinational pharmaceutical companies due to the high ...
See all reports like this >>

More China Prescription Drugs reports

China Pharmaceutical Mfg. Industry Data Report by Beijing Zeefer Consulting Ltd.
China Pharmaceutical Mfg. Industry Data ReportThis data report provides key statistics and concise analysis on pharmaceutical mfg. industry in China. It presents an overview on ...
Databook Q1 2014: China Social Media Advertising Spend - Pharmaceutical & Healthcare Industry by Socintel360
Databook Q1 2014: China Social Media Advertising Spend in Pharmaceutical & Healthcare IndustrySocial media advertising spend by pharmaceutical & healthcare brands in China stood at ...
Databook Q1 2014: China Digital Advertising Spend - Pharmaceutical & Healthcare Industry by Socintel360
Databook Q1 2014: China Digital Advertising Spend in Pharmaceutical & Healthcare IndustryOnline advertising spend by pharmaceutical & healthcare brands in China stood at US$511 million ...
Chemical Pharmaceutical: China Chemical Pharmaceutical Industry Report, 2013-2016 by Research in China
Chemical Pharmaceutical: China Chemical Pharmaceutical Industry Report, 2013-2016 Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!